Research
Hormonal
Tirzepatide achieved up to 20.9% weight loss over 72 weeks in non-diabetic obese individuals.
Tirzepatide can be considered an effective option for weight management in non-diabetic obese patients.
StrongSupportsmedium confidence
Synthesized evidence indicated that tirzepatide achieved up to 20.9% weight loss over 72 weeks (SURMOUNT-1).
Why this rating
The claim is supported by synthesized evidence from clinical trials.
Source
Efficacy and Safety of Tirzepatide for Weight Management in Non-Diabetic Obese Individuals: A Narrative Review
Mohammed Sallam et al. · Obesities · 2025
Meta-analysisCited 7×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →